Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility.
Saved in:
| Title: | Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility. |
|---|---|
| Authors: | van Blokland IV; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Lanting P; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Ori APS; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Vonk JM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Warmerdam RCA; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Herkert JC; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Boulogne F; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Claringbould A; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Structural Computational Biology unit, EMBL, Heidelberg, Germany., Lopera-Maya EA; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Bartels M; Department of Biological Psychology, FGB, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, The Netherlands., Hottenga JJ; Department of Biological Psychology, FGB, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Ganna A; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland., Karjalainen J; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.; Broad Institute of MIT and Harvard, Cambridge, MA, United States of America.; Analytic and Translational Genetics Unit (ATGU), Massachusetts General Hospital, Boston, MA, United States of America., Hayward C; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom., Fawns-Ritchie C; Department of Psychology, University of Edinburgh, Edinburgh, United Kingdom., Campbell A; Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom., Porteous D; Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom., Cirulli ET; Helix OpCo LLC, San Mateo, California, United States of America., Schiabor Barrett KM; Helix OpCo LLC, San Mateo, California, United States of America., Riffle S; Helix OpCo LLC, San Mateo, California, United States of America., Bolze A; Helix OpCo LLC, San Mateo, California, United States of America., White S; Helix OpCo LLC, San Mateo, California, United States of America., Tanudjaja F; Helix OpCo LLC, San Mateo, California, United States of America., Wang X; Helix OpCo LLC, San Mateo, California, United States of America., Ramirez JM 3rd; Helix OpCo LLC, San Mateo, California, United States of America., Lim YW; Helix OpCo LLC, San Mateo, California, United States of America., Lu JT; Helix OpCo LLC, San Mateo, California, United States of America., Washington NL; Helix OpCo LLC, San Mateo, California, United States of America., de Geus EJC; Department of Biological Psychology, FGB, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, The Netherlands., Deelen P; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands., Boezen HM; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Franke LH; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. |
| Corporate Authors: | Lifelines COVID-19 cohort study, COVID-19 Host Genetics Initiative |
| Source: | PloS one [PLoS One] 2021 Aug 11; Vol. 16 (8), pp. e0255402. Date of Electronic Publication: 2021 Aug 11 (Print Publication: 2021). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0255402 |
